Focus Diagnostics Home
 Home  About Focus Diagnostics  Employment  Contact Us
USA International Certifications Customer Service Account Setup Contact Us Compliance Commitment
Kit Description Photo Guide Schematic FAQ Back to Product List
IF0600G Epstein-Barr Virus (EBV) VCA IFA IgG
Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides, IgG conjugate, and positive and negative controls.
 
  open pdf document Package Inserts
 

EBV VCA IFA (IF0600G)

Slide 1 Slide 2
Negative Positive
VCAIgGNEG.jpg (13536 bytes) VCAIgGPOS.jpg (14579 bytes)
Back to Top
 

EBV VCA IgG Slide Schematic


Back to Top
Frequently Asked Questions (FAQ)
Q: The cells on this IFA slide all appear positive. Is this possible?

A: If all the cells are positive this is likely to be some type of an anti-cellular reaction. The percent positive should be approximately the same as seen with the positive control.

Q: When only two or three cells are seen fluorescing is this a positive?

A: No, the percent of positive cells seen should be at least as high as the number of positive cells seen with the positive control at its endpoint.



Q: Why is the positive control for this IFA kit barely positive at the screening dilution?

A: The positive controls are bottled at the screening dilution and can be titered for an endpoint from this dilution. The control should be used in the first well without further dilution.



Q: Can the VCA IgG slides be used for IgM testing?

A: We do not recommend this these slides are not optimized for IgM testing. the VCA IgM RIFA kit RIF0600M was specifically designed for VCA IgM testing.

Back to Top
Epstein-Barr Virus (EBV) VCA IFA IgG
       
Back to Product List  
       
First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics


FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics


Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.


 
©2010 - Focus Diagnostics - All Rights Reserved - Site Revision ID: WEB.FOCUSDX.C3 - Privacy Policy - Site Map